The search for the etiologic agent for Kaposi sarcoma led to the discovery of Kaposi
sarcoma-associated herpesvirus (KSHV) in 1994. KSHV, also called human herpesvirus-8 …

Kaposi sarcoma herpesvirus (KSHV), taxonomical name human gammaherpesvirus 8, is a
phylogenetically old human virus that co-evolved with human populations, but is now only …

Background Most of the world's population is not covered by cancer surveillance systems or
vital registration, and worldwide/UN-regional cancer incidence is estimated using a variety …

Background Kaposi sarcoma is a rare, possibly angioproliferative, tumour. Kaposi sarcoma
is one of the most common cancers in people living with HIV and poses a serious public …

Background Optimal treatment regimens for AIDS-associated Kaposi sarcoma, a frequent
contributor to morbidity and mortality among people with HIV, have not been systematically …

T cell responses to Kaposi's sarcoma-associated herpesvirus (KSHV) are likely essential in
the control of KSHV infection and protection from associated disease, but remain poorly …

Kaposi's sarcoma herpesvirus (KSHV) establishes lifelong infection and persists in latently
infected B cells. Paradoxically, in vitro B cell infection is inefficient, and cells rapidly die …

Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr Virus (EBV) establish
life-long infections and are associated with malignancies. Striking geographic variation in …

Simple Summary Kaposi's sarcoma-associated herpesvirus (KSHV) is one of the seven
oncogenic viruses currently recognized by the International Agency for Research on Cancer …

Kaposi's sarcoma‐associated herpesvirus (KSHV) and Epstein–Barr virus (EBV) are
prevalent in sub‐Saharan Africa, together with HIV; the consequent burden of disease is …